Pharmaceutical Levofloxacin Powder Material Levofloxacin Powder Levofloxacin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung Levofloxacin
• Shelf Life: 2 Years
• Mf: C18h20fn3o4
• MW: 361.37
• Melting Point: 218°c
• Density: 1.48
• Boiling Point: 571.5°cat760mmhg
• Refractive Index: 1.669
• Flash Point: 299.4°c
• Psa: 73.32
• Logp: 0.84
• Mdl: Mfcd00865049
• Brn: 7327015
• Pubchem: 24857060
• Rtecs: Uu8815550
• Storage Conditions: Store at 0-5ºC
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• HS Code: 29349990
• Production Capacity: 10000kg/Month

Product Description

Pharmaceutical Levofloxacin powder Material Levofloxacin powder Levofloxacin

Product Description

Product Details

MF:	C18H20FN3O4
MW:	361.37
CAS:	100986-85-4
EINECS login number:	600-146-0

Levofloxacin, one of the quinolones, has a broad-spectrum antibacterial effect. Strong antibacterial effect, against most Enterobacteriaceae bacteria, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella and Haemophilus influenzae, Legionella pneumophila, Neisseria gonorrhoeae It has strong antibacterial activity against Gram-negative bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes and other Gram-positive bacteria, Mycoplasma pneumoniae, Chlamydia pneumoniae, but it also has antibacterial effect on anaerobic bacteria and Enterococcus. less effective.

Application&Function

Funlication
Levofloxacin, the indication is this product, suitable for the following moderate and severe infections caused by sensitive bacteria: respiratory infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bronchiolitis, bronchiectasis combined infection, pneumonia, Tonsillitis (peritonsillar abscess); Urinary system infection: pyelonephritis, complicated urinary tract infection, etc.; Reproductive system infection: acute prostatitis, acute epididymitis, uterine cavity infection, accessory uterine inflammation, pelvic inflammatory disease (suspected of anaerobic bacteria Metronidazole can be used in combination with infection); Skin and soft tissue infections: infectious impetigo, cellulitis, lymphatic (nodular) inflammation, subcutaneous abscess, perianal abscess, etc.; intestinal infection: bacterial dysentery, infectious enteritis, Salmonella enteritis, typhoid fever and paratyphoid fever; various infections in patients with sepsis, neutropenia, and immunocompromised; other infections: mastitis, trauma, burns and postoperative wound infections, abdominal cavity infections (combined metronidazole if necessary) , Cholecystitis, cholangitis, bone and joint infections, and ENT infections.
 

Specification